Marker Therapeutics, Inc. ( MRKR) - Stock Earnings
MRKR Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 12, 2026, midnight | — / — | — | — / — | — |
MRKR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -1.7 million USD | 1.1 million USD |
| 2026Q1 | -3.2 million USD | — USD |
| 2026Q2 | -1.8 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
MRKR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -8.2 million USD | 3.3 million USD |
| 2024 | -10.7 million USD | 6.6 million USD |
| 2025 | -12.2 million USD | 3.5 million USD |
| 2026 Est. | — | — |
MRKR
Price: $1.15
52 week price:
Earnings Per Share: -0.38 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 156064
Market Capitalization: 19.2 million